Community monitoring exposes where HIV, TB and malaria programs still run in parallel
Global responses to HIV, tuberculosis, and malaria have delivered major gains, but the model that drove much of that progress is under strain. Vertical programs and parallel systems can move quickly when donor resources are strong, yet they also leave behind fragmented patient pathways, duplicated reporting structures, and service gaps that become harder to sustain when external funding tightens. In that setting, integration is no longer a policy slogan. It is a practical response to shrinking support and a way to keep essential services functioning inside public health systems.
A community case study published in Frontiers in Public Health draws on secondary community-led monitoring reports from more than 4,000 health facilities across 16 African countries. The analysis focuses on integration priorities aligned with the Global Fund to Fight AIDS, Tuberculosis and Malaria. Rather than relying only on administrative data or national policy documents, the work centers the experience of people who move through clinics, laboratories, and referral pathways every day. Their reports expose where separate disease programs still collide at the point of care.
The clearest pattern is persistent fragmentation. Patients still face multiple visits to complete services that could be delivered together, and TB/HIV co-infection care remains uneven in many settings. Coordination between programs is often weak, leaving people to navigate systems that do not communicate well with one another. For a person seeking diagnosis, treatment, follow-up, or referral, those failures can translate into delays, repeated transport costs, and missed opportunities to begin care promptly.
Same-day services and linked care emerge as the most concrete fixes
Community-led monitoring has already been used to push for more integrated service delivery. Same-day care is one of the most direct examples. When HIV testing, TB screening, and related clinical steps can be delivered during a single visit, the burden on patients drops immediately. The same logic extends beyond infectious disease services. CLM data have also supported stronger links between HIV care and sexual and reproductive health, gender-based violence support, and mental health services.
These connections matter because clinical need rarely arrives in a single-disease package. A patient who comes to a clinic for HIV care may also need contraception, support after violence, depression screening, or TB evaluation. A system built around separate programs can miss those overlapping needs, especially when each program uses its own workflow, staff, and reporting expectations. Integrated care creates a more realistic clinical pathway, particularly for communities that already face travel barriers, stigma, or repeated out-of-pocket costs.
The case study also points to donor transition periods as a high-risk moment. As external financing shifts, vertical programs may be asked to fold into broader primary health care platforms. That transition can either strengthen continuity or expose weaknesses in staffing, procurement, supervision, and referral systems. CLM offers a way to document those failures in real time and present them in a form that health ministries, implementers, and funders can act on.
Unified monitoring and stronger systems determine whether integration lasts
Service integration cannot work if information systems stay fragmented. The report describes CLM being used to support unified monitoring frameworks, with community data incorporated into national systems. That shift is more than an administrative exercise. When community evidence reaches decision-makers, it can shape how bottlenecks are identified, which districts need support, and whether reforms are actually reaching facilities. It also gives policy makers a view of service quality that routine reporting may miss.
The systems implications extend well beyond clinic flow. CLM has informed advocacy around integrated sample transportation systems, a practical issue that often determines whether a test result returns in time to influence care. When specimens move through separate channels for different diseases, delays accumulate and results can be lost. Integrated transport models reduce duplication and can make laboratory services easier to coordinate across programs.
Supply chains and workforce capacity are just as important. The case study notes that CLM is being used to support improvements in these areas, along with broader laboratory strengthening. A clinic cannot offer integrated services if essential medicines, test kits, or trained staff are missing. In that setting, integration becomes a paper design rather than a working model. Community monitoring helps show whether the promise of integration is reaching the point of care or stopping at policy language.
Social health insurance expansion also appears in the analysis as part of the broader reform agenda. Coverage mechanisms influence whether patients can actually access services after the formal restructuring of programs. If insurance is limited or fragmented, integration inside the clinic may still leave people exposed to financial barriers outside it. Community evidence can help make those gaps visible before they become entrenched.
Community actors are shaping integration, not just observing it
One of the most important themes in the case study is the role of community actors themselves. CLM is not merely a feedback channel. It is a mechanism through which affected communities help define what integration should look like in practice. That includes identifying where referrals fail, where service combinations are missing, and where patients are being asked to make multiple trips for care that should be coordinated.
This matters because integration is often discussed at a systems level, while the actual failures are experienced at the bedside, in waiting rooms, at the pharmacy counter, or in the laboratory queue. Community-led data bridge that gap. They turn patient experience into evidence that can be used in advocacy, planning, and reform. In regions where health systems must do more with less, that kind of evidence can be especially useful.
The broader lesson is straightforward. Integrated monitoring tools are needed if integrated care is the goal. Separate disease programs can no longer be managed as isolated islands when funding is shrinking and health systems are being asked to absorb more responsibility. The African CLM experience shows how community-generated evidence can expose fragmentation, support practical service redesign, and inform decisions about labor, laboratory networks, transport, and insurance.
What remains unresolved is how consistently those insights will be translated into durable national reforms. The case study shows where integration is needed and how community monitoring can help drive it, but the harder work lies in whether health systems can institutionalize those changes across facilities, programs, and donor transitions without losing the gains already made in HIV, TB, and malaria care.